Discriminative stimulus properties of atypical and typical antipsychotic drugs: A review of preclinical studies

Psychopharmacology

Volumn 203, Issue 2, 2009, Pages 279-294

  Porter, Joseph H ^a   Prus, Adam J ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b NORTHERN MICHIGAN UNIVERSITY   (United States)

Author keywords

Antipsychotic drugs; Clozapine; Discriminative stimulus properties; Drug discrimination; Mice; Monkeys; Pigeons; Rats; Schizophrenia; Training dose

Indexed keywords

1 [2 (4 FLUOROBENZAMIDO)ETHYL] 4 (7 METHOXY 1 NAPHTHYL)PIPERAZINE; 2 DIPROPYLAMINO 5,6 DIMETHOXYINDAN; 3 [[4 (4 CHLOROPHENYL) 1 PIPERAZINYL]METHYL] 1H PYRROLO[2,3 B]PYRIDINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; AMITRIPTYLINE; ATYPICAL ANTIPSYCHOTIC AGENT; BEMESETRON; CHLORDIAZEPOXIDE; CHLORPROMAZINE; CLOZAPINE; CYPROHEPTADINE; DOPAMINE 4 RECEPTOR; HALOPERIDOL; HISTAMINE H1 RECEPTOR; IMIPRAMINE; MIANSERIN; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; NEUROLEPTIC AGENT; OLANZAPINE; ONDANSETRON; PROMETHAZINE; QUETIAPINE; SCOPOLAMINE; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN 6 RECEPTOR; SEROTONIN 7 RECEPTOR; THIORIDAZINE; TRIHEXYPHENIDYL; UNINDEXED DRUG; ZIPRASIDONE;

ASSOCIATION; BEHAVIOR; DISCRIMINATIVE STIMULUS; DRUG DOSE REDUCTION; DRUG MECHANISM; DRUG RECEPTOR BINDING; LOW DRUG DOSE; NONHUMAN; PIGEON; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR OCCUPANCY; REVIEW; SCHIZOPHRENIA;

ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; CLOZAPINE; DISCRIMINATION (PSYCHOLOGY); DRUG EVALUATION, PRECLINICAL; PSYCHOPHARMACOLOGY; RECEPTORS, CHOLINERGIC; RECEPTORS, DOPAMINE; RECEPTORS, SEROTONIN;

EID: 62449312238     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-008-1308-3     Document Type: Review

References (114)

1. 1-adrenoceptor antagonists substitute for the discriminative stimulus properties of NMDA in rats. Poster presented at the meeting of the Society for Neuroscience, New Orleans, October 1997
2. J Arnt T Skarsfeldt 1998 Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence Neuropsychopharmacology 18 63 101
3. H Barry III ML Steenberg AA Manian JP Buckley 1974 Effects of chlorpromazine and three metabolites on behavioral responses in rats Psychopharmacology (Berlin) 34 351 360
4. JD Brioni DJB Kim AB O'Neill JEG Williams MW Decker 1994 Clozapine attenuates the discriminative stimulus properties of (-)-nicotine Brain Res 643 1 9
5. Browne RG, Koe BK (1982) Clozapine and agents with similar behavioral and biochemical properties. In: Colpaert FC, Slangen JL (eds) Drug discrimination: applications in CNS pharmacology. Elsevier Biomedical, Amsterdam, pp 241-254
6. FP Bymaster DO Calligaro JF Falcone RD Marsh NA Moore NC Tye P Seeman DT Wong 1996 Radioreceptor binding profile of the atypical antipsychotic olanzapine Neuropsychopharmacology 14 87 96
7. GJ Carey J Bergman 1997 Discriminative-stimulus effects of clozapine in squirrel monkeys: comparison with conventional and novel antipsychotic drugs Psychopharmacology 132 261 269
8. E Casey 1989 Clozapine: neuroleptic-induced EPS and tardive dyskinesia Psychopharmacology 99 S47 S53
9. J Claghorn G Honigfeld FS Abuzzanab R Wang R Steinbook V Tauson G Klerman 1987 The risks and benefits of clozapine versus chlorpromazine J Clin Psychopharmacol 7 377 384
10. C Cohen DJ Sanger G Perrault 1997 Characterization of the discriminative stimulus produced by the dopamine antagonist tiapride J Pharmacol Exp Ther 283 566 573
11. JC Cole M Field HR Sumnall AJ Goudie 2007 Potentiation of olanzapine substitution in rats discriminating clozapine by the D2/3 agonist quinpirole Behav Pharmacol 18 3 185 190
12. FC Colpaert 1999 Drug discrimination in neurobiology Pharmacol Biochem Behav 64 2 337 345
13. FC Colpaert CJE Niemegeers PAJ Janssen 1976 Theoretical and methodological considerations on drug discrimination learning Psychopharmacologia (Berl.) 46 169 177
14. Cooper JR, Bloom FE, Roth RH (1996) The biochemical basis of neuropharmacology. Oxford University Press, New York, p 92
15. Crow T (1987) Positive and negative symptoms in schizophrenia. In: Henn FA, DeLisi LE (eds) Neurochemistry and neuropharmacology of Schizophrenia. Elsevier Science, New York, pp 178-189
16. MA Davies BA Compton-Toth SJ Hufeisen HY Meltzer BL Roth 2004 The highly efficacious actions of N-desmethylclozapine at muscarinic receptors are unique and not a common property of either typical or atypical antipsychotic drugs: is M(1) agonism a pre-requisite for mimicking clozapine's actions? Psychopharmacology 178 451 460
17. 2A antagonist, MDL100,907. Neuropharmacology 44:604-615
18. C Dolder M Nelson Z Deyo 2008 Paliperidone for schizophrenia Am J Health-Syst Pharm 65 403 413
19. H Dlugosz HA Nasrallah 2007 Paliperidone: a new extended-release oral atypical antipsychotic Expert Opin Pharmacother 8 2307 2313
20. BA Ellenbroek 1993 Treatment of schizophrenia: a clinical and preclinical evaluation of neuroleptic drugs Pharmac Ther 57 1 78
21. BA Ellenbroek A Cools 1990 Animals models with construct validity for schizophrenia Behav Pharmacol 1 469 490
22. SR Franklin AH Tang 1994 Discriminative stimulus effects of clozapine in rats Behav Pharmacol 5 113
23. D Gauvin SA Vanacek TJ Baird RJ Briscoe KL Carl FA Holloway CA Sannerud 1998 The stimulus properties of two common over-the-counter drug mixtures: dextromethorphan + ephedrine and dextromethorphan + diphenhydramine J Psychopharmacol 12 84 92
24. MA Geyer B Ellenbroek 2003 Animal behavior models of the mechanisms underlying antipsychotic atypicality Progress Neuro-Psychopharmacol & Biol Psychiatry 27 1071 1079
25. WM Glazer 1999 Does loxapine have "atypical" properties? Clinical evidence J Clin Psychiatry 60 Suppl 10 42 46
26. JA Goas JE Boston Jr 1978 Discriminative stimulus properties of clozapine and chlorpromazine Pharmacol Biochem Behav 8 235 241
27. PR Golds FR Przyslo PG Strange 1980 The binding of some antidepressant drugs to brain muscarinic acetylcholine receptors British J Pharmacol 68 541 549
28. AJ Goudie JA Smith 1999 Discriminative stimulus properties of antipsychotics Pharmacol Biochem Behav 64 2 193 201
29. AJ Goudie A Taylor 1998 Comparative characterisation of the discriminative stimulus properties of clozapine and other antipsychotics in rats Psychopharmacology 135 392 400
30. AJ Goudie A Taylor 1998 Olanzapine generalisation to the clozapine discriminative stimulus is determined by clozapine training dose British J Pharmacol 124S 54
31. AJ Goudie MAI Taylor JA Smith 1998 Stimulus properties of clozapine and related agents in rats at two clozapine training doses J Psychopharmacol 12 Suppl 226
32. AJ Goudie MAI Taylor JA Smith 1998 Converting olanzapine into clozapine in rats J Psychopharmacol 12 Suppl A57
33. AJ Goudie JA Smith A Taylor MAI Taylor MD Tricklebank 1998 Discriminative stimulus properties of the atypical neuroleptic clozapine in rats: tests with subtype selective receptor ligands Behav Pharmacol 9 699 710
34. 3 preferring antagonist PNU-99194A: an analysis of possible mechanisms Behav Pharmacol 12 303 315
35. AJ Goudie JA Smith JC Cole 2004 Stimulus properties of the "atypical" antipsychotic zotepine in rats: comparisons with clozapine and quetiapine Pharmacol Biochem Behav 77 163 173
36. AJ Goudie JA Smith MJ Millan 2004 Characterization of the effects of receptor-selective ligands in rats discriminating the novel antipsychotic quetiapine Psychopharmacology 171 212 222
37. AJ Goudie GD Cooper JC Cole HR Sumnall 2006 Cyproheptadine resembles clozapine in vivo following both acute and chronic administration in rats J Psychopharmacol 21 2 179 190
38. AJ Goudie JC Cole HR Sumnall 2007 Olanzapine and JL13 induce cross-tolerance to the clozapine discriminative stimulus in rats Behav Pharmacol 18 9 17
39. Harris RT, Balster RL (1971) An analysis of the function of drugs in the stimulus control of operant behavior. In: Thompson T, Pickens R (eds) Stimulus properties of drugs. Meredith, New York, NY, pp 111-132
40. EM Hoenicke SA Vanecek JH Woods 1992 The discriminative stimulus effects of clozapine in pigeons: involvement of 5-hydroxytryptamine-1c and 5-hydroxytryptamine-2 receptors J Pharmacol Exp Ther 263 276 284
41. G Honigfeld J Patin J Singer 1984 Clozapine: antipsychotic activity in treatment-resistant schizophrenics Adv Ther 1 77 97
42. A Imperato L Dazzi MC Obinu GL Gessa G Biggio 1994 The benzodiazepine receptor antagonist flumazenil increases acetylcholine release in rat hippocampus Brain Res 647 167 171
43. 1C receptors and antidepressants Prog Neuropsychopharmacol Psychiatry 18 563 574
44. J Kane G Honigfeld J Singer H Meltzer 1988 Clozapine for the treatment-resistant schizophrenic: a double-blind comparison versus chlorpromazine/benztropine Arch Gen Psychiatry 45 789 796
45. S Kapur SC Vanderspek BA Brownlee JN Nobrega 2003 Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy J Pharmacol Exp Ther 305 625 631
46. BM Kelley JH Porter 1997 The role of muscarinic cholinergic receptors in the discriminative stimulus properties of clozapine in rats Pharmacol Biochem Behav 57 707 719
47. BM Kelley KA Nuti JH Porter 1994 Further evidence for muscarinic antagonism as clozapine's discriminative stimulus Society for Neuroscience Abstracts 20 1637
48. BM Kelley JH Porter SA Varvel 1995 Mianserin as a discriminative stimulus in rats: asymmetrical cross-generalization with scopolamine Psychopharmacology 120 491 493
49. S Lewis J Lieberman 2008 CATIE and CUtLASS: can we handle the truth? Br J Psychiatry 192 161 163
50. 2 antagonist Mol Pharmacol 27 600 611
51. Z Li M Huang J Ichikawa J Dai HY Meltzer 2005 N-desmethylclozapine, a major metabolite of clozapine, increases cortical acetylcholine and dopamine release in vivo via stimulation of M1 muscarinic receptors Neuropsychopharmacology 30 1986 1995
52. JA Lieberman BL Saltz CA Johns S Pollack J Kane 1989 Clozapine effects on tardive dyskinesia Psychopharmacol Bull 25 57 62
53. JF McElroy JJ Stimmel JM O'Donnell 1989 Discriminative stimulus properties of haloperidol Drug Dev Res 18 47 55
54. Meert TF (1991) Application of drug discrimination with drugs of abuse to develop new therapeutic agents. In: Glennon RA, Jarbe TUC, Frankenheim J (eds) Drug discrimination: application to drug abuse research. NIDA (Research Monograph 116), Rockville, MD, pp 307-323
55. Meltzer HY (1992) The mechanism of action of clozapine in relation to its clinical advantages. In: Meltzer HY (ed) Novel antipsychotic drugs. Raven, New York, pp 1-13
56. HY Meltzer DJ Luchins 1984 Effects of clozapine in severe tardive dyskinesia: a case report J Clin Psychopharmacol 4 316 322
57. HY Meltzer K Jayathilake 1999 Low-dose loxapine in the treatment of schizophrenia: is it more effective and more "atypical" than standard-dose loxapine? J Clin Psychiatry 60 Suppl 10 47 51
58. HY Meltzer SR McGurk 1999 The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia Schizo Bull 25 2 233 255
59. HY Meltzer S Matsubara JC Lee 1989 Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values J Pharmacol Exp Ther 251 238 46
60. JM Meyer 2007 Antipsychotic safety and efficacy concerns J Clin Psychiatry 68 Suppl 14 20 26
61. 1A Receptors J Pharmacol Exp Ther 295 853 861
62. 1A agonist properties: II. functional profile in comparison to clozapine and haloperidol J Pharmacol Exp Ther 286 1356 1373
63. 1A agonist properties. IV. a drug discrimination comparison with clozapine J Pharmacol Exp Ther 289 427 436
64. MJ Millan M Brocco JM Rivet V Audinot A Newman-Tancredi L Maiofiss S Queriaux N Despaux JL Peglion A Dekeyne 2000 S18327 (1-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1)- and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine, and 11 other antipsychotic agents J Pharmacol Exp Ther 292 54 66
65. HJ Möller 2003 Amisulpride: limbic specificity and the mechanism of antipsychotic atypicality Prog Neuropsychopharmacol Biol Psychiatry 27 7 1101 1111
66. NA Moore NC Tye MS Axton FC Risius 1992 The behavioral pharmacology of olanzapine, a novel "atypical" antipsychotic agent J Pharmacol Exp Ther 262 545 551
67. NA Moore DO Calligaro DT Wong F Bymaster NC Tye 1993 The pharmacology of olanzapine and other new antipsychotic agents Cur Opin Invest Drugs 2 281 293
68. A Newman-Tancredi M-B Assie N Leduc A-M Ormiere N Danty C Cosi 2005 Novel antipsychotics activate recombinant human and native rat serotonin 5-HT1A receptors: affinity, efficacy and potential implications for treatment of schizophrenia Int J Neuropsychopharmacology. 8 1 16
69. EB Nielsen 1988 Cholinergic mediation of the discriminative stimulus properties of clozapine Psychopharmacology 94 115 118
70. R Ortmann JG Meisburger S Bischoff K Hauser H Bittiger PC Waldmeier 1986 The clozapine cue in rats as tools for the characterization of neuroleptics Psychopharmacology 89 S47
71. DA Overton 1966 State dependent learning produced by depressant and atropine-like drugs Psychopharmacology (Berlin) 10 6 31
72. DA Overton 1982 Comparison of the degree of discriminability of various drugs using the T-maze drug discrimination paradigm Psychopharmacology 76 385 395
73. SD Philibin AJ Prus AL Pehrson JH Porter 2005 Serotonin receptor mechanisms mediate the discriminative stimulus properties of the atypical antipsychotic clozapine in C57BL/6 mice Psychopharmacology (Berl) 180 1 49 56
74. Philibin SD, Walentiny DM, Vunck SA, Prus, Meltzer HY, Porter JH (2008) Further characterization of the discriminative stimulus properties of the atypical antipsychotic drug clozapine in C57BL/6 mice. Psychopharmacology (this issue)
75. JH Porter SE Strong 1996 Discriminative stimulus control with olanzapine: generalization to the atypical antipsychotic clozapine Psychopharmacology 128 216 219
76. JH Porter HE Covington III SA Varvel RE Vann TA Warren 1998 Chlorpromazine as a discriminative stimulus in rats: generalization to typical and atypical antipsychotic Drug Dev Res 48 38 44
77. 2 dopamine receptors in the discriminative stimulus properties of the atypical antipsychotic clozapine in rats Drug Dev Res 46 139 147
78. JH Porter SE McCallum SA Varvel RE Vann 2000 The discriminative stimulus properties of the atypical antipsychotic olanzapine in rats Psychopharmacology 148 224 233
79. JH Porter SA Varvel RE Vann SD Philibin LE Wise 2000 Clozapine drug discrimination with a low training dose distinguishes atypical from typical antipsychotic drugs in rats Psychopharmacology 149 189 193
80. JH Porter AJ Prus RE Vann SA Varvel 2005 Discriminative stimulus properties of the atypical antipsychotic clozapine and the typical antipsychotic chlorpromazine in a three-choice drug discrimination procedure in rats Psychopharmacology (Berl) 178 67 77
81. JH Porter DM Walentiny SC Philibin SA Vunck JC Crabbe 2008 A comparison of the discriminative stimulus properties of the atypical antipsychotic drug clozapine in DBA/2 and C57BL/6 inbred mice Behav Pharmacol 19 530 542
82. AJ Prus LE Baker HY Meltzer 2004 Discriminative stimulus properties of 1.25 and 5.0 mg/kg doses of clozapine in rats: examination of the role of dopamine, serotonin, and muscarinic receptor mechanisms Pharmacol Biochem Behav 77 199 208
83. AJ Prus SD Philibin AL Pehrson JH Porter 2005 Generalization to atypical antipsychotic drugs depends on training dose in rats trained to discriminate 1.25 mg/kg clozapine versus 5.0 mg/kg clozapine versus vehicle in a three-choice drug discrimination task Behav Pharmacol 16 511 520
84. AJ Prus SD Philibin AL Pehrson CL Stephens RN Cooper LE Wise JH Porter 2005 Generalization testing with atypical and typical antipsychotic drugs in rats trained to discriminate 5.0 mg/kg clozapine from vehicle in a two-choice drug discrimination task Drug Dev Res 64 55 65
85. AJ Prus SD Philibin AL Pehrson JH Porter 2006 Discriminative stimulus properties of the atypical antipsychotic drug clozapine in rats trained to discriminate 1.25 mg/kg clozapine vs5.0 mg/kg clozapine vs. vehicle Behav Pharmacol 17 185 194
86. Prus AJ, Pehrson AL, Philibin SD, Wood JT, Vunck SA, Porter JH (2008) The role of M1 muscarinic cholinergic receptors in the discriminative stimulus properties of N-desmethylclozapine and the atypical antipsychotic drug clozapine. Psychopharmacology (this issue)
87. Reuters (2008) ACADIA pharmaceuticals announces results from ACP-104 Phase IIb Schizophrenia Trial. Press Release, June 16, 2008 http://www.reuters. com/article/pressRelease/idUS100572+16-Jun-2008+BW20080616
88. GP Reynolds 1997 What is an atypical antipsychotic? J Psychopharmacol 11 195 199
89. E Richelson 1999 Receptor pharmacology of neuroleptics: relation to clinical effects J Clin Psychiatry 60 Suppl 10 5 14
90. 1C receptors J Pharmacol Exp Ther 260 1361 1365
91. BL Roth MC Craigo MS Choudhary A Uluer FJ Monsma Jr Y Shen HY Meltzer DR Sibley 1994 Binding of typical and atypical antipsychotics agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors J Pharmacol Exp Ther 268 1403 1410
92. R Schreiber M Brocco MJ Millan 1994 Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone Eur J Pharmacol 264 99 102
93. Schmidt WJ, Volz TL (1992) Clozapine-like discriminate stimulus effects of N-methyl-d-aspartate (NMDA). Journal of Psychopharmacology (Suppl.), Abstract: BAP and EBPS Joint Meeting, Cambridge
94. Schuster CR, Balster RL (1997) The discriminative stimulus properties of drugs. In: Thompson T, Dews PB (eds) Advances in behavioral pharmacology (Vol. 1). Academic, New York, pp 85-138
95. A Schotte PFM Janssen W Gommeren WHML Luyten P Van Gompel AS Lesag K De Loore JE Leysen 1996 Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding Psychopharmacology 124 57 73
96. DA Shapiro S Renock E Arrington LA Chiodo LX Liu DR Sibley BL Roth R Mailman 2003 Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology Neuropsychopharmacology 28 1400 1411
97. JA Smith AJ Goudie 2002 Discriminative stimulus properties in rats of the novel antipsychotic quetiapine Exp Clin Psychopharmacol 10 376 384
98. JA Smith A Taylor AJ Goudie IC Kilpatrick PL Needham 1998 Discriminative stimulus properties of the antipsychotic zotepine in clozapine cued rats J Psychopharmacol 12 Suppl A57
99. SM Sorensen JH Kehne GM Fadayel TM Humphreys HJ Ketteler CK Sullivan VL Taylor CJ Schmidt 1993 Characterization of the 5-HT2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: behavioral, electrophysiological and neurochemical studies J Pharmacol Exp Ther 266 684 691
100. J Stewart 1962 Differential responses based on the physiological consequences of pharmacological agents Psychopharmacologia 3 132 138
101. IP Stolerman EA Mariathasan J-AW White 1994 Implications of mixture research for discrimination of single drugs Behav Pharmacol 5 Suppl 18
102. Stolerman IP, White J-AW, Mariathasan EA (1996) Generalizations between mixtures of drugs under "AND" and "AND-OR" discrimination procedures in rats. In: Harris LS (ed) Problems of drug dependence 1995.NIDA Monograph 162, U.S. Government Printing Office, Washington, DC, p 214
103. AH Tang SR Franklin CS Himes MW Smith RE Tenbrink 1997 PNU-96415E, a potential antipsychotic agent with clozapine-like pharmacological properties J Pharmacol Exp Ther 281 440 447
104. SA Varvel RE Vann LE Wise JH Porter 1999 Discriminative stimulus control with olanzapine: generalization to the atypical antipsychotic sertindole Society for Neuroscience Abstracts 25 1571
105. HF Villanueva S Arezo JA Rosecrans JH Porter 1990 Discriminative stimulus properties of clozapine Society for Neuroscience Abstracts 16 248
106. HF Villanueva S Arezo JA Rosecrans 1992 Nicotine does not interact with the discriminative stimulus effects of clozapine in rats Drug Dev Res 26 2 195 202
107. DM Weiner HY Meltzer I Veinbergs EM Donohue TA Spalding TT Smith N Mohell SC Harvey J Lameh N Nash KE Vanover R Olsson K Jayathilake M Lee AI Levey U Hacksell ES Burstein RE Davis MR Brann 2004 The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine Psychopharmacology (Berl) 177 207 216
108. JL Wiley JH Porter 1992 Serotonergic drugs do not substitute for clozapine in clozapine-trained rats in a two-lever drug discrimination procedure Pharmacol Biochem Behav 43 961 965
109. JL Wiley JH Porter 1993 Effects of serotonergic drugs in rats trained to discriminate clozapine from haloperidol Bull Psychonomic Society 31 94 96
110. Winter JC, Rabin RA (1989) Yohimbine and serotonergic agonists: stimulus properties and receptor binding. In: Lal H, Fielding S (eds) Drugs as interoceptive stimuli. Drug Dev Res 16:327-333
111. E Wood AL Pehrson JT Wood AJ Prus HY Meltzer JH Porter 2007 The discriminative stimulus properties of the atypical antipsychotic ziprasidone in rats. Poster Presented at the 12th Biennial European Behavioral Pharmacology Society meeting in Tubingen, Germany Abstract Published in Behavioural Pharmacology 18 Suppl 1 S70
112. ND Woodward SE Purdon HY Meltzer DH Zald 2005 A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia Intern J Neuropsychopharmacol 8 1 16
113. CR Young JG Longhurst MB Bowers Jr CM Mazure 1997 The expanding indications for clozapine Exp Clin Psychopharm 5 216 234
114. XP Zeng F Le E Richelson 1997 Muscarinic m4 receptor activation by some atypical antipsychotic drugs Eur J Pharmacol 321 3 349 54